These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15310457)

  • 1. Mitochondria as cancer drug targets.
    Don AS; Hogg PJ
    Trends Mol Med; 2004 Aug; 10(8):372-8. PubMed ID: 15310457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy: targeting the mitochondrial cell death pathway.
    Debatin KM; Poncet D; Kroemer G
    Oncogene; 2002 Dec; 21(57):8786-803. PubMed ID: 12483532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism.
    Pathania D; Millard M; Neamati N
    Adv Drug Deliv Rev; 2009 Nov; 61(14):1250-75. PubMed ID: 19716393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioenergetic pathways in tumor mitochondria as targets for cancer therapy and the importance of the ROS-induced apoptotic trigger.
    Ralph SJ; Rodríguez-Enríquez S; Neuzil J; Moreno-Sánchez R
    Mol Aspects Med; 2010 Feb; 31(1):29-59. PubMed ID: 20026172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of AIF-mediated caspase-independent programmed cell death.
    Lorenzo HK; Susin SA
    Drug Resist Updat; 2007 Dec; 10(6):235-55. PubMed ID: 18180198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antimitochondrial agents: a new class of anticancer agents].
    André N; Rome A; Carré M;
    Arch Pediatr; 2006 Jan; 13(1):69-75. PubMed ID: 16298120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancratistatin: a natural anti-cancer compound that targets mitochondria specifically in cancer cells to induce apoptosis.
    McLachlan A; Kekre N; McNulty J; Pandey S
    Apoptosis; 2005 May; 10(3):619-30. PubMed ID: 15909123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of p38 MAPK and JNK in Arsenic trioxide-induced mitochondrial cell death in human cervical cancer cells.
    Kang YH; Lee SJ
    J Cell Physiol; 2008 Oct; 217(1):23-33. PubMed ID: 18412143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria as targets for cancer therapy.
    Ralph SJ; Neuzil J
    Mol Nutr Food Res; 2009 Jan; 53(1):9-28. PubMed ID: 19123183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro model of normal, immortalized ovarian surface epithelial and ovarian cancer cells for chemoprevention of ovarian cancer.
    Brewer M; Wharton JT; Wang J; McWatters A; Auersperg N; Gershenson D; Bast R; Zou C
    Gynecol Oncol; 2005 Aug; 98(2):182-92. PubMed ID: 15907982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimelanoma activity of apoptogenic carbonyl scavengers.
    Wondrak GT; Jacobson MK; Jacobson EL
    J Pharmacol Exp Ther; 2006 Feb; 316(2):805-14. PubMed ID: 16210394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondria as therapeutic targets for cancer chemotherapy.
    Galluzzi L; Larochette N; Zamzami N; Kroemer G
    Oncogene; 2006 Aug; 25(34):4812-30. PubMed ID: 16892093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell cycle arrest and proapoptotic effects of the anticancer cyclodepsipeptide serratamolide (AT514) are independent of p53 status in breast cancer cells.
    Soto-Cerrato V; Montaner B; Martinell M; Vilaseca M; Giralt E; Pérez-Tomás R
    Biochem Pharmacol; 2005 Dec; 71(1-2):32-41. PubMed ID: 16298346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin E analogues as a novel group of mitocans: anti-cancer agents that act by targeting mitochondria.
    Neuzil J; Dong LF; Ramanathapuram L; Hahn T; Chladova M; Wang XF; Zobalova R; Prochazka L; Gold M; Freeman R; Turanek J; Akporiaye ET; Dyason JC; Ralph SJ
    Mol Aspects Med; 2007; 28(5-6):607-45. PubMed ID: 17499351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation and interplay of apoptotic and non-apoptotic cell death.
    Kim R; Emi M; Tanabe K; Murakami S; Uchida Y; Arihiro K
    J Pathol; 2006 Feb; 208(3):319-26. PubMed ID: 16261658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential of vitamin K3 as an anticancer agent against breast cancer that acts via the mitochondria-related apoptotic pathway.
    Akiyoshi T; Matzno S; Sakai M; Okamura N; Matsuyama K
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):143-50. PubMed ID: 19449007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective targeting of mitochondria for the treatment of cancer.
    Dilda PJ; Hogg PJ
    Discov Med; 2005 Feb; 5(25):70-3. PubMed ID: 20704927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting mitochondrial permeability in cancer drug development.
    Berridge MV; Herst PM; Lawen A
    Mol Nutr Food Res; 2009 Jan; 53(1):76-86. PubMed ID: 19035550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Akt-mediated cisplatin resistance in ovarian cancer: modulation of p53 action on caspase-dependent mitochondrial death pathway.
    Yang X; Fraser M; Moll UM; Basak A; Tsang BK
    Cancer Res; 2006 Mar; 66(6):3126-36. PubMed ID: 16540663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rerouting chlorambucil to mitochondria combats drug deactivation and resistance in cancer cells.
    Fonseca SB; Pereira MP; Mourtada R; Gronda M; Horton KL; Hurren R; Minden MD; Schimmer AD; Kelley SO
    Chem Biol; 2011 Apr; 18(4):445-53. PubMed ID: 21513881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.